MCG lab designated to help with patient testing for NCI-MATCH trial -- MEDICA - World Forum for Medicine

MCG lab designated to help with patient testing for NCI-MATCH trial

11/02/2018

Image: Dr. Ravindra Kohle and Augusta OncoTarget; Copyright: Phil Jones / Augusta University

Dr. Ravindra Kolhe, molecular pathologist, director of the GEM Laboratory in the MCG Department of Pathology and primary developer of the new test called Augusta OncoTarget.